AMICUS THERAPEUTICS INC AMICUS - Price History
Monthly price history for 0HF9.L (AMICUS THERAPEUTICS INC AMICUS )
Date | Adjusted price | Real price |
---|---|---|
May 2024 | $10.04 | $10.04 |
April 2024 | $10.14 | $10.14 |
March 2024 | $11.71 | $11.71 |
February 2024 | $12.80 | $12.80 |
January 2024 | $12.71 | $12.71 |
December 2023 | $14.25 | $14.25 |
November 2023 | $10.94 | $10.94 |
October 2023 | $10.90 | $10.90 |
September 2023 | $12.13 | $12.13 |
August 2023 | $12.96 | $12.96 |
July 2023 | $13.40 | $13.40 |
June 2023 | $12.56 | $12.56 |
May 2023 | $11.03 | $11.03 |
April 2023 | $11.64 | $11.64 |
March 2023 | $10.81 | $10.81 |
February 2023 | $13.21 | $13.21 |
January 2023 | $12.92 | $12.92 |
December 2022 | $12.06 | $12.06 |
November 2022 | $11.84 | $11.84 |
October 2022 | $10.30 | $10.30 |
September 2022 | $10.39 | $10.39 |
August 2022 | $11.58 | $11.58 |
July 2022 | $9.75 | $9.75 |
June 2022 | $10.90 | $10.90 |
May 2022 | $7.92 | $7.92 |
April 2022 | $7.79 | $7.79 |
March 2022 | $9.93 | $9.93 |
February 2022 | $8.12 | $8.12 |
January 2022 | $9.29 | $9.29 |
December 2021 | $11.72 | $11.72 |
November 2021 | $10.85 | $10.85 |
October 2021 | $10.60 | $10.60 |
September 2021 | $9.65 | $9.65 |
August 2021 | $11.36 | $11.36 |
July 2021 | $9.41 | $9.41 |
June 2021 | $9.78 | $9.78 |
May 2021 | $9.50 | $9.50 |
April 2021 | $10.15 | $10.15 |
March 2021 | $9.62 | $9.62 |
February 2021 | $12.15 | $12.15 |
January 2021 | $19.10 | $19.10 |
December 2020 | $24.73 | $24.73 |
May 2019 | $10.75 | $10.75 |
April 2019 | $13.62 | $13.62 |
March 2019 | $13.63 | $13.63 |
February 2019 | $12.39 | $12.39 |
January 2019 | $11.96 | $11.96 |
September 2018 | $12.14 | $12.14 |
August 2018 | $14.61 | $14.61 |
July 2018 | $16.10 | $16.10 |
June 2018 | $15.88 | $15.88 |
May 2018 | $15.75 | $15.75 |
April 2018 | $14.02 | $14.02 |
March 2018 | $14.47 | $14.47 |
February 2018 | $15.14 | $15.14 |
January 2018 | $16.03 | $16.03 |
0HF9.L
Price: $9.42
52 week price:
Earnings Per Share: -0.97 USD
P/E Ratio: -13.54
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 31.6 million